About this episode

The episode discusses coding challenges related to saturation biopsy and cystoscopy risk, emphasizing the importance of interpretation in these areas.

April 3, 2026 In this episode, Scott, Mark, and Dr. Ray Painter tackle two areas where interpretation is driving real-world coding challenges: when a prostate biopsy truly qualifies as a stereotactic template-guided saturation biopsy (55706), and whether diagnostic cystoscopy meets moderate risk under E/M guidelines. The discussion breaks down what differentiates saturation biopsy from standard transperineal approaches, including the importance of 3D templating and full-gland sampling...

People in this episode

Hosts: Scott Painter, Mark Painter, Dr. Ray Painter

Topics covered

• saturation biopsy
• cystoscopy risk
• coding challenges
• prostate biopsy
• E/M guidelines
• 3D templating
• full-gland sampling

Keywords

• saturation biopsy
• cystoscopy
• coding
• prostate biopsy
• E/M guidelines
• 3D templating
• transperineal approaches

More episodes of Urology Coding and Reimbursement Podcast

• UCR 288: New Technology in Urology – Don’t Let Reimbursement Be an Afterthought · May 8, 2026 · 22 min
• UCR 286: C9761 Clarified – What Actually Qualifies and What’s at Risk · April 24, 2026 · 33 min
• UCR 285: Bringing More Complex Procedures Into the Office – Is It Worth It? · April 17, 2026 · 30 min
• UCR 284: UTI PCR Under Fire – OIG Scrutiny, Denials, and What to Do Next · April 10, 2026 · 29 min
• UCR 282: Playing the Surgical Lottery – Medicare Advantage and Out-of-Network Strategy · March 27, 2026 · 36 min
• UCR 281: UnitedHealthcare’s New Documentation Rule and MDM Data Clarifications · March 20, 2026 · 34 min

Explore listener stats, chart rankings, contacts and more on the Urology Coding and Reimbursement Podcast podcast page.